Skip to main content

Roche uses artificial intelligence for cancer diagnosis

| News

Roche uses artificial intelligence for cancer diagnosis


Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help pathology labs diagnose cancer. Roche describes the partnership as a step forward in personalized medicine.

Roche headquarters in Basel (image: Roche)

The Basel-based life sciences company Roche is collaborating with Ibex Medical Analytics of Israel and the United States-based Amazon subsidiary Amazon Web Services, according to a statement. The partners are pooling their services to help pathology labs diagnose cancer.

The new solution builds on Roche’s navify Digital Pathology software platform, which now offers AI algorithms from Ibex. The entire system is based on an Amazon Web Services cloud infrastructure.

Laboratories can access the software platform and initially use it for the diagnosis of breast and prostate cancer. The system’s decision support tools are expected to increase turnaround time in laboratories and boost productivity.

AI in personalized medicine in the Basel Area

With the new partnership, Roche says it is expanding its commitment to “improving patient care and advancing personalized healthcare through innovation”.

The Metropolitan Region of the Upper Rhine and the Basel Area offer fertile ground for developments based on the use of AI in personalized medicine. A number of regional initiatives aim to support innovation in this field, for example. The region also promotes knowledge and technology transfer from key stakeholders.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.